Adjust medication if necessary: If the decreased appetite is causing too many problems for your child and not improving after they have been on the medication for a while, some adjustments may need to be made.Keep snacks around for your child to grab when they feel hungry throughout the day. Offer snacks: If they didn't eat lunch but they are hungry after school, offer them a nutritious snack.Don't force them to eat: Instead of forcing your child to eat when they don't have an appetite, schedule eating around when they tend to be hungry.Make the food they eat count: Provide them with a variety of nutritious, high-calorie, nutrient-dense food choices.Plan for them to be hungrier in the evening when their medication is wearing off, and provide enough food to make up for the lunch they may not have eaten. Plan medication around mealtimes: Try administering medication after your child has had a filling, nutritious breakfast so they are hungry enough to eat.
Dextroamphetamine/amphetamine has a high potential for abuse and is contraindicated for use in this setting. Dextroamphetamine/amphetamine, dexmethylphenidate, lisdexamfetamine, and methylphenidate should be used cautiously in patients with a history of substance abuse because prolonged administration can lead to physical and psychological drug dependence.Patients should be closely monitored while taking atomoxetine. Atomoxetine increases the risk of suicidal ideation and/or suicidal behavior.These stimulants can cause increases in blood pressure and heart rate and can lead to myocardial infarction and sudden unexplained death (SUD). Dextroamphetamine/amphetamine, dextroamphetamine, and methamphetamine should not be used in patients with cardiac disease.Dexmethylphenidate and methylphenidate are contraindicated in patients with tics or Tourette's syndrome (including a family history of Tourette's syndrome) since they may worsen these conditions.ĭexmethylphenidate and methylphenidate should be used cautiously in patients with a history of alcoholism because prolonged administration can lead to physical and psychological drug dependence.Dextroamphetamine/ amphetamine and dextroamphetamine also have a Black Box Warning for this reason. Dextroamphetamine/amphetamine, dextroamphetamine, and methamphetamine are contraindicated in patients with a history of substance abuse since stimulants can cause physical and psychological drug dependence.tachyarrhythmia in this patient population.Atomoxetine can cause serious reactions, including Atomoxetine is contraindicated in patients with pheochromocytoma or a history of pheochromocytoma.Such combinations can cause a hypertensive crisis. Atomoxetine, dextroamphetamine/amphetamine, dextroamphetamine, dexmethylphenidate, lisdexamfetamine, and methamphetamine should not be combined with monoamine oxidase inhibitors ( MAOI) or used within 14 days of stopping an MAOI.Therefore they are contraindicated for use in patients with hyperthyroidism. Stimulation of the sympathetic nervous system by dextroamphetamine/amphetamine, dextroamphetamine, methamphetamine, and methylphenidate can cause cardiac arrhythmias.Methylphenidate (Metadate CD) contains sucrose and is contraindicated in patients with hereditary fructose intolerance, glucose- galactose malabsorption, and sucrase-isomaltase deficiency.Atomoxetine is contraindicated in closed-angle glaucoma due to the risk of mydriasis ( pupil dilation).
This is because stimulants can block the outflow of aqueous humor (eye fluid) and increase intraocular pressure. Dextroamphetamine/amphetamine, dextroamphetamine, dexmethylphenidate, methamphetamine, and methylphenidate are contraindicated in people with glaucoma due to the risk of visual disturbances and blurred vision.Methamphetamine also has a Black Box Warning for this reason. Methamphetamine and methylphenidate are contraindicated for use in patients with cardiac disease.